Published in Gut on September 01, 1999
Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ (2010) 4.69
Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut (2006) 3.00
Present status and strategy of NSAIDs-induced small bowel injury. J Gastroenterol (2009) 1.70
Non-invasive investigation of inflammatory bowel disease. World J Gastroenterol (2001) 1.54
Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science (2016) 1.44
Capsule endoscopic diagnosis of nonsteroidal antiinflammatory drug-induced enteropathy. J Gastroenterol (2009) 1.24
Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs. Gut (2001) 1.24
Ileitis: when it is not Crohn's disease. Curr Gastroenterol Rep (2010) 1.12
Utility of faecal calprotectin analysis in adult inflammatory bowel disease. World J Gastroenterol (2012) 1.12
Exercise-induced splanchnic hypoperfusion results in gut dysfunction in healthy men. PLoS One (2011) 1.10
Validation and clinical significance of a new calprotectin rapid test for the diagnosis of gastrointestinal diseases. Int J Colorectal Dis (2008) 1.09
Fecal calprotectin in inflammatory bowel disease. Clin Exp Gastroenterol (2016) 1.05
Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma. Gut (2001) 1.04
Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice. BMC Musculoskelet Disord (2006) 1.01
Is non-steroidal anti-inflammaory drug (NSAID) enteropathy clinically more important than NSAID gastropathy? Postgrad Med J (2006) 1.01
Faecal calprotectin concentrations in apparently healthy children aged 0-12 years in urban Kampala, Uganda: a community-based survey. BMC Pediatr (2011) 0.95
Non-steroidal anti-inflammatory drug-induced enteropathy. Clin Endosc (2012) 0.93
Diagnostic utility of faecal biomarkers in patients with irritable bowel syndrome. World J Gastroenterol (2014) 0.93
Biomarkers in inflammatory bowel diseases: current status and proteomics identification strategies. World J Gastroenterol (2014) 0.93
Endoscopic features of chronic nonspecific multiple ulcers of the small intestine: comparison with nonsteroidal anti-inflammatory drug-induced enteropathy. Dig Dis Sci (2006) 0.92
Soluble ST2: a new and promising activity marker in ulcerative colitis. World J Gastroenterol (2011) 0.91
Fecal calprotectin levels in patients with colonic polyposis. Dig Dis Sci (2007) 0.89
Non-steroidal anti-inflammatory drugs as a risk factor for acute diarrhoea: a case crossover study. Gut (2003) 0.87
Fecal calprotectin use in inflammatory bowel disease and beyond: A mini-review. Can J Gastroenterol Hepatol (2015) 0.86
Fecal calprotectin in children with the enthesitis-related arthritis subtype of juvenile idiopathic arthritis. J Rheumatol (2011) 0.86
The microbiota-derived metabolite indole decreases mucosal inflammation and injury in a murine model of NSAID enteropathy. Gut Microbes (2016) 0.86
Utility of neutrophil Fcγ receptor I (CD64) index as a biomarker for mucosal inflammation in pediatric Crohn's disease. Inflamm Bowel Dis (2014) 0.84
Rebamipide suppresses diclofenac-induced intestinal permeability via mitochondrial protection in mice. World J Gastroenterol (2012) 0.83
Determining small bowel integrity following drug treatment. Br J Clin Pharmacol (2003) 0.82
Fecal calprotectin and elastase 1 determinations in patients with pancreatic diseases: a possible link between pancreatic insufficiency and intestinal inflammation. J Gastroenterol (2007) 0.82
Impact of diets with a high content of greaves-meal protein or carbohydrates on faecal characteristics, volatile fatty acids and faecal calprotectin concentrations in healthy dogs. BMC Vet Res (2013) 0.82
MR enterography to evaluate sub-clinical intestinal inflammation in children with spondyloarthritis. Pediatr Rheumatol Online J (2012) 0.81
Recent Advances in NSAIDs-Induced Enteropathy Therapeutics: New Options, New Challenges. Gastroenterol Res Pract (2013) 0.81
Biomarkers in management of inflammatory bowel disease. Prz Gastroenterol (2013) 0.81
The influence of a short-term gluten-free diet on the human gut microbiome. Genome Med (2016) 0.80
Disease monitoring in inflammatory bowel disease. World J Gastroenterol (2015) 0.80
Protective effect of metronidazole on uncoupling mitochondrial oxidative phosphorylation induced by NSAID: a new mechanism. Gut (2001) 0.80
Calprotectin as a diagnostic tool for inflammatory bowel diseases. Biomed Rep (2016) 0.79
Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease. J Gastroenterol (2016) 0.79
A protective effect of melatonin on intestinal permeability is induced by diclofenac via regulation of mitochondrial function in mice. Acta Pharmacol Sin (2011) 0.78
Differential diagnosis between functional and organic intestinal disorders: is there a role for non-invasive tests? World J Gastroenterol (2007) 0.78
Elevated levels of serum MRP8/14 in ankylosing spondylitis: associated with peripheral arthritis and active disease. Clin Rheumatol (2016) 0.77
The Role of Laboratory Tests in Crohn's Disease. Clin Med Insights Gastroenterol (2016) 0.76
The Pig PeptideAtlas: A resource for systems biology in animal production and biomedicine. Proteomics (2016) 0.76
The Gut Mucosal Firewall and Functional Medicine. Integr Med (Encinitas) (2016) 0.75
Does calprotectin level identify a subgroup among patients suffering from irritable bowel syndrome? Results of a prospective study. United European Gastroenterol J (2016) 0.75
Fecal calprotectin in juvenile idiopathic arthritis patients related to drug use. Pediatr Rheumatol Online J (2017) 0.75
Experimental peritonitis induced by oral administration of indomethacin in Mongolian gerbils. J Vet Sci (2006) 0.75
Muscovite is protective against non-steroidal anti-inflammatory drug-induced small bowel injury. World J Gastroenterol (2014) 0.75
Fecal Calprotectin, Elastase, and Alpha-1-Antitrypsin Levels After Roux-en-Y Gastric Bypass; Calprotectin Is Significantly Elevated in the Majority of Patients. Obes Surg (2016) 0.75
Fecal Calprotectin in Healthy Children Aged 1-4 Years. PLoS One (2016) 0.75
Serious upper gastrointestinal complications of NSAIDs and COX-2 selective agents. Inflammopharmacology (2011) 0.75
Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage. Br Med J (Clin Res Ed) (1985) 4.30
Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med (1992) 4.27
Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut (1987) 4.26
Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans. Gastroenterology (1987) 3.24
Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol (1992) 3.09
Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs. Lancet (1984) 2.83
Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test. Gut (1996) 2.41
Small bowel enteroscopy in undiagnosed gastrointestinal blood loss. Gut (1992) 2.15
Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine. Gut (1986) 2.10
Blood and protein loss via small-intestinal inflammation induced by non-steroidal anti-inflammatory drugs. Lancet (1987) 1.99
NSAID induced gastrointestinal complications: the ARAMIS perspective--1997. Arthritis, Rheumatism, and Aging Medical Information System. J Rheumatol Suppl (1998) 1.94
Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein. Digestion (1997) 1.92
Nonsteroidal anti-inflammatory drug-induced enteropathy: case discussion and review of the literature. Mayo Clin Proc (1995) 1.59
The biochemical basis of non-steroidal anti-inflammatory drug-induced damage to the gastrointestinal tract: a review and a hypothesis. Scand J Gastroenterol (1995) 1.57
Ileocolonoscopic findings in seronegative spondylarthropathies. Br J Rheumatol (1988) 1.55
Distribution of a new myelomonocytic antigen (L1) in human peripheral blood leukocytes. Immunofluorescence and immunoperoxidase staining features in comparison with lysozyme and lactoferrin. Am J Clin Pathol (1985) 1.53
Upper gastrointestinal findings and faecal occult blood in patients with rheumatic diseases taking nonsteroidal anti-inflammatory drugs. Br J Rheumatol (1987) 1.51
Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy. Gut (1992) 1.47
Gastrointestinal events in patients prescribed non-steroidal anti-inflammatory drugs: a controlled study using record linkage in Tayside. Q J Med (1989) 1.31
Faecal calprotectin shedding after short-term treatment with non-steroidal anti-inflammatory drugs. Scand J Gastroenterol (1996) 1.13
Preliminary evidence for gut involvement in the pathogenesis of rheumatoid arthritis? Br J Rheumatol (1986) 1.12
"Diaphragm-like" strictures of the small bowel in patients treated with non-steroidal anti-inflammatory drugs. Br J Radiol (1990) 1.10
Non-steroidal anti-inflammatory drugs: how do they damage the gut? Br J Rheumatol (1994) 1.09
Importance of local versus systemic effects of non-steroidal anti-inflammatory drugs in increasing small intestinal permeability in man. Gut (1991) 1.06
Increased intestinal permeability in patients with rheumatoid arthritis: a side-effect of oral nonsteroidal anti-inflammatory drug therapy? Br J Rheumatol (1987) 1.03
Nonsteroidal antiinflammatory drug-induced small intestinal inflammation and blood loss. Effects of sulfasalazine and other disease-modifying antirheumatic drugs. Arthritis Rheum (1994) 0.98
Comparison of leukocyte excretion and blood loss in inflammatory disease of the bowel. Gut (1993) 0.90
Small-bowel enteroscopy and NSAID ulceration. Lancet (1991) 0.89
Short report: the effect of misoprostol on the anaemia of NSAID enteropathy. Aliment Pharmacol Ther (1994) 0.85
Lack of correlation between fecal blood loss and drug-induced gastric mucosal lesions. Gastrointest Endosc (1988) 0.82
Strength-duration curves for repetitive stimulation of medullated nerve. J Physiol (1934) 15.94
Integration of cytogenetic landmarks into the draft sequence of the human genome. Nature (2001) 10.96
Growth of factor-dependent hemopoietic precursor cell lines. J Exp Med (1980) 5.80
A dust-obscured massive maximum-starburst galaxy at a redshift of 6.34. Nature (2013) 4.43
Regulation of mammalian circadian behavior by non-rod, non-cone, ocular photoreceptors. Science (1999) 3.96
Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer (1983) 3.94
The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century. Rheumatology (Oxford) (2002) 3.87
Abscisic acid signaling through cyclic ADP-ribose in plants. Science (1997) 3.55
Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology (2000) 3.49
Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med (1985) 3.41
Autosomal linkage between the Gm and Pi loci in man. Ann Hum Genet (1972) 3.34
Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans. Gastroenterology (1987) 3.24
Diaphragm disease: pathology of disease of the small intestine induced by non-steroidal anti-inflammatory drugs. J Clin Pathol (1988) 3.21
Sequences flanking the hexameric G-box core CACGTG affect the specificity of protein binding. Plant Cell (1992) 3.09
Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol (1992) 3.09
Osmotic significance of glycerol accumulation in exponentially growing yeasts. Appl Environ Microbiol (1987) 3.06
Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs. Lancet (1984) 2.83
Heatstroke in well-wrapped infants. Lancet (1979) 2.81
WWOX: a candidate tumor suppressor gene involved in multiple tumor types. Proc Natl Acad Sci U S A (2001) 2.79
Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet (1990) 2.73
NSAIDs, Cox-2 inhibitors, and the gut. Lancet (1995) 2.72
Plant bZIP protein DNA binding specificity. J Mol Biol (1993) 2.71
A simple method for assessing intestinal inflammation in Crohn's disease. Gut (2000) 2.69
A persistent defect in intestinal permeability in coeliac disease demonstrated by a 51Cr-labelled EDTA absorption test. Lancet (1983) 2.62
Group A beta-hemolytic streptococci resistant to erythromycin and lincomycin. N Engl J Med (1968) 2.44
Bilateral human fetal striatal transplantation in Huntington's disease. Neurology (2002) 2.34
The leaky gut of alcoholism: possible route of entry for toxic compounds. Lancet (1984) 2.30
Absorption of 51chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease. Gastroenterology (1983) 2.23
Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut (1996) 2.23
Roles of alpha-toxin and beta-toxin in virulence of Staphylococcus aureus for the mouse mammary gland. Infect Immun (1989) 2.23
Methane-oxidizing microorganisms. Microbiol Rev (1981) 2.17
Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial. Ann Intern Med (1996) 2.17
The polymorphism of "prealbumins" and alpha-1-antitrypsin in human sera. Clin Chim Acta (1967) 2.14
Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis (2008) 2.12
How should different life expectancies be valued? BMJ (1998) 2.10
Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine. Gut (1986) 2.10
BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis. Rheumatology (Oxford) (2007) 2.02
Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroenterol (1999) 2.02
Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force. Ann Rheum Dis (2007) 2.01
Functional and clinical aspects of the myelomonocyte protein calprotectin. Mol Pathol (1997) 1.98
Endomysial antibody: is it the best screening test for coeliac disease? Gut (1992) 1.93
Serum Pi types in patients with pulmonary diseases. Acta Allergol (1969) 1.86
Food intolerance and Crohn's disease. Gut (1993) 1.84
Serum prealbumin: polymorphism in man. Science (1965) 1.81
Isolation and characterisation of a bipotential haematopoietic cell line. Nature (1979) 1.80
The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J Clin Endocrinol Metab (1996) 1.80
Quantitative studies on the inherited variants of serum alpha-1-antitrypsin. Scand J Clin Lab Invest (1969) 1.79
Lactulose, 51Cr-labelled ethylenediaminetetra-acetate, L-rhamnose and polyethyleneglycol 400 [corrected] as probe markers for assessment in vivo of human intestinal permeability. Clin Sci (Lond) (1986) 1.78
Early Permian bipedal reptile. Science (2000) 1.73
International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology (Oxford) (2003) 1.71
The Pi system-inherited variants of serum alpha 1-antitrypsin. Prog Med Genet (1970) 1.69
Two functional states of the CD11b A-domain: correlations with key features of two Mn2+-complexed crystal structures. J Cell Biol (1998) 1.67
The Pi polymorphism: genetic, biochemical, and clinical aspects of human alpha 1-antitrypsin. Adv Hum Genet (1981) 1.67
Cell death, chromosome damage and mitotic delay in normal human, ataxia telangiectasia and retinoblastoma fibroblasts after x-irradiation. Int J Radiat Biol Relat Stud Phys Chem Med (1981) 1.66
Report of Nomenclature Meeting for alpha 1-antitrypsin, INSERM, Rouen/Bois-Guillaume-1978. Hum Genet (1980) 1.66
Bone marrow colony-stimulating activity of serum from mice with viral-induced leukemia. J Natl Cancer Inst (1967) 1.63
The effect of elemental diet on intestinal permeability and inflammation in Crohn's disease. Gastroenterology (1991) 1.61
Increased chromosomal radiosensitivity in breast cancer patients: a comparison of two assays. Int J Radiat Biol (1999) 1.61
Hepatic resection of metastatic testicular carcinoma: a further update. Ann Surg Oncol (1999) 1.59
Control of specific gene expression by gibberellin and brassinosteroid. Plant Physiol (2001) 1.57
The biochemical basis of non-steroidal anti-inflammatory drug-induced damage to the gastrointestinal tract: a review and a hypothesis. Scand J Gastroenterol (1995) 1.57
Bone marrow colony stimulating activity in human sera. Results of two independent surveys in Buffalo and Melbourne. Br J Haematol (1968) 1.56
Non-invasive investigation of inflammatory bowel disease. World J Gastroenterol (2001) 1.54
Intestinal absorptive capacity, intestinal permeability and jejunal histology in HIV and their relation to diarrhoea. Gut (1995) 1.54
Distribution of a new myelomonocytic antigen (L1) in human peripheral blood leukocytes. Immunofluorescence and immunoperoxidase staining features in comparison with lysozyme and lactoferrin. Am J Clin Pathol (1985) 1.53
Mitochondrial damage: a possible mechanism of the "topical" phase of NSAID induced injury to the rat intestine. Gut (1997) 1.53
Sexual mimicry regulates the attractiveness of mated Drosophila melanogaster females. Proc Natl Acad Sci U S A (1986) 1.52
Heritability of cellular radiosensitivity: a marker of low-penetrance predisposition genes in breast cancer? Am J Hum Genet (1999) 1.51
Enhanced intracoronary thrombolysis with urokinase using a novel, local drug delivery system. In vitro, in vivo, and clinical studies. Circulation (1995) 1.50
Tumour induction by methyl-nitroso-urea following preconceptional paternal contamination with plutonium-239. Br J Cancer (1998) 1.50
Structure, organization, and regulation of human metallothionein IF gene: differential and cell-type-specific expression in response to heavy metals and glucocorticoids. Mol Cell Biol (1986) 1.49
Biological, pathological and physical characterization of a possible variant of a murine sarcoma virus (Moloney). Int J Cancer (1968) 1.47
Genetic predisposition in breast cancer. Lancet (1994) 1.47
The male-specific histocompatibility antigen, H-Y: a history of transplantation, immune response genes, sex determination and expression cloning. Annu Rev Immunol (1997) 1.46
Interleukin-12 and pre-eclampsia. J Reprod Immunol (1997) 1.45
The Ovarian Tumor Index predicts risk for malignancy. Cancer (1999) 1.45
Serum Pi types in Norwegians. Acta Pathol Microbiol Scand (1967) 1.44
Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. QJM (2000) 1.44
A pilot study of 2-chloro-2'-deoxyadenosine in the treatment of systemic lupus erythematosus-associated glomerulonephritis. Arthritis Rheum (1998) 1.43
Ontogenic development of lamb intestinal sodium-glucose co-transporter is regulated by diet. J Physiol (1991) 1.42
Intestinal permeability in patients with Crohn's disease and their first degree relatives. Gut (1992) 1.42
Adjuvant bleomycin, etoposide and cisplatin in pathological stage II non-seminomatous testicular cancer. the Indiana University experience. Eur J Cancer (2000) 1.42
Small intestinal transit, absorption, and permeability in patients with AIDS with and without diarrhoea. Gut (1999) 1.42
Small intestine permeability in schizophrenia. Br J Psychiatry (1989) 1.41
Raised leucocyte levels as a marker for post-tonsillectomy haemorrhage - a useful tool? Clin Otolaryngol (2010) 1.41
Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer. Radiother Oncol (2000) 1.39
Defining new standards for adjuvant therapy of testis cancer. J Clin Oncol (1995) 1.39
Increased expression of c-myc proto-oncogene in biopsies of ulcerative colitis and Crohn's colitis. Gut (1992) 1.38
The action potentials in maia nerve before and after poisoning with veratrine and yohimbine hydrochlorides. J Physiol (1935) 1.38
Hyaluronan secretion into the synovial cavity of rabbit knees and comparison with albumin turnover. J Physiol (1997) 1.38
Ten years' experience with an elemental diet in the management of Crohn's disease. Gut (1990) 1.37
Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer. Clin Cancer Res (2001) 1.37